These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38488949)

  • 21. Relationships between PET and blood plasma biomarkers in corticobasal syndrome.
    Singh NA; Alnobani A; Graff-Radford J; Machulda MM; Mielke MM; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Kanekiyo T; Josephs KA; Whitwell JL
    Alzheimers Dement; 2024 Jul; 20(7):4765-4774. PubMed ID: 38885334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population.
    Ohara T; Tatebe H; Hata J; Honda T; Shibata M; Matsuura S; Mikami T; Maeda T; Ono K; Mimura M; Nakashima K; Iga JI; Takebayashi M; Tokuda T; Ninomiya T;
    Psychiatry Clin Neurosci; 2024 Jun; 78(6):362-371. PubMed ID: 38606661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies.
    Vrillon A; Bousiges O; Götze K; Demuynck C; Muller C; Ravier A; Schorr B; Philippi N; Hourregue C; Cognat E; Dumurgier J; Lilamand M; Cretin B; Blanc F; Paquet C
    Alzheimers Res Ther; 2024 Jul; 16(1):146. PubMed ID: 38961441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Stevenson-Hoare J; Heslegrave A; Leonenko G; Fathalla D; Bellou E; Luckcuck L; Marshall R; Sims R; Morgan BP; Hardy J; de Strooper B; Williams J; Zetterberg H; Escott-Price V
    Brain; 2023 Feb; 146(2):690-699. PubMed ID: 35383826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study.
    Chen Y; Wang Y; Tao Q; Lu P; Meng F; Zhuang L; Qiao S; Zhang Y; Luo B; Liu Y; Peng G
    Clin Chim Acta; 2024 May; 558():118784. PubMed ID: 38588788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    McGrath ER; Beiser AS; O'Donnell A; Yang Q; Ghosh S; Gonzales MM; Himali JJ; Satizabal CL; Johnson KA; Tracy RP; Seshadri S
    J Alzheimers Dis; 2022; 87(4):1517-1526. PubMed ID: 35491781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
    Twait EL; Kamarioti M; Verberk IMW; Teunissen CE; Nooyens ACJ; Monique Verschuren WM; Visser PJ; Huisman M; Kok AAL; Eline Slagboom P; Beekman M; Vojinovic D; Lakenberg N; Arfan Ikram M; Schuurmans IK; Wolters FJ; Moonen JEF; Gerritsen L; van der Flier WM; Geerlings MI;
    Am J Geriatr Psychiatry; 2024 Sep; 32(9):1141-1153. PubMed ID: 38553327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
    Pereira JB; Janelidze S; Smith R; Mattsson-Carlgren N; Palmqvist S; Teunissen CE; Zetterberg H; Stomrud E; Ashton NJ; Blennow K; Hansson O
    Brain; 2021 Dec; 144(11):3505-3516. PubMed ID: 34259835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers.
    Orduña Dolado A; Stomrud E; Ashton NJ; Nilsson J; Quijano-Rubio C; Jethwa A; Brum WS; Brinkmalm Westman A; Zetterberg H; Blennow K; Janelidze S; Hansson O
    Alzheimers Res Ther; 2024 Jun; 16(1):132. PubMed ID: 38909218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF Aβ
    Lim YY; Yassi N; Bransby L; Ayton S; Buckley RF; Eratne D; Velakoulis D; Li QX; Fowler C; Masters CL; Maruff P
    Neurobiol Aging; 2023 Sep; 129():209-218. PubMed ID: 37399739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions.
    Zheng HT; Wu Z; Mielke MM; Murray AM; Ryan J
    J Prev Alzheimers Dis; 2024; 11(5):1189-1197. PubMed ID: 39350363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice.
    Verberk IMW; Jutte J; Kingma MY; Vigneswaran S; Gouda MMTEE; van Engelen MP; Alcolea D; Arranz J; Fortea J; Lleó A; Chevalier C; Marizzoni M; van de Giessen EM; Lemstra AW; Pijnenburg YAL; van der Flier WM; den Braber A; Wilson D; Schut MC; van Harten AC; Teunissen CE
    Alzheimers Dement; 2024 Sep; 20(9):6115-6132. PubMed ID: 39096164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
    Ferreira PCL; Zhang Y; Snitz B; Chang CH; Bellaver B; Jacobsen E; Kamboh MI; Zetterberg H; Blennow K; Pascoal TA; Villemagne VL; Ganguli M; Karikari TK
    Alzheimers Dement; 2023 Oct; 19(10):4507-4519. PubMed ID: 36876954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
    Beyer L; Stocker H; Rujescu D; Holleczek B; Stockmann J; Nabers A; Brenner H; Gerwert K
    Alzheimers Dement; 2023 Mar; 19(3):1020-1028. PubMed ID: 35852967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
    Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
    Johansson C; Thordardottir S; Laffita-Mesa J; Rodriguez-Vieitez E; Zetterberg H; Blennow K; Graff C
    Brain; 2023 Mar; 146(3):1132-1140. PubMed ID: 36626935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and predictive power of plasma proteins in Alzheimer's disease: a cross-sectional and longitudinal study in China.
    Li W; Sun L; Yue L; Xiao S
    Sci Rep; 2024 Jul; 14(1):17557. PubMed ID: 39080359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study.
    Perna L; Stocker H; Burow L; Beyer L; Trares K; Kurz C; Gürsel S; Holleczek B; Tatò M; Beyreuther K; Mons U; Gerwert K; Perneczky R; Schöttker B; Brenner H
    Alzheimers Res Ther; 2023 Nov; 15(1):198. PubMed ID: 37951931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.